The following review is a compilation of the recent advances and knowledge on the behaviour of the most frequently used compounds to treat inflammatory bowel disease in an organism. It considers clinical aspects of each entity and the pharmacokinetic/pharmacodynamic relationship supported by the use of plasma monitoring, tissue concentrations, and certain aspects derived from pharmacogenetics.
|Numero di pagine||27|
|Rivista||European Journal of Clinical Pharmacology|
|Stato di pubblicazione||Pubblicato - 2015|
- inflammatory bowel disease